Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 5 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell 3 Leukemia, Myeloid, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Breast Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Unresectable Pancreatic Carcinoma 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Kaposi 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Melanoma 1 Lymphoma 1 Lymphohistiocytosis, Hemophagocytic 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Colitis 1 Castleman Disease 1 Carcinoma, Transitional Cell 1 Carcinoma, Neuroendocrine 1

Interventions

tocilizumab 1 fish oil triglycerides 1 Methylprednisolone 1 Diagnosis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colitis × tocilizumab × Clear all

NCT03601611 2020-04-21

COLAR

Herlev Hospital

Phase NA Completed

Arthritis, Colitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡